Purified Polypeptide Detection of Ehrlichia chaffeensis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current assays for detecting Ehrlichia chaffeensis antibodies are limited by sensitivity and specificity issues due to the impure nature of Ehrlichia antigens, leading to cross-reactions with E. canis antibodies in vaccinated animals.
Innovation Solution
Development of purified polypeptides comprising less than 50 contiguous naturally occurring Ehrlichia chaffeensis amino acids, which can be linked with indicator reagents or other sequences for enhanced detection, and methods for detecting specific antibodies or infections using these polypeptides.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If impure Ehrlichia antigens are used in detection assays, then the assays can be constructed with available materials, but the sensitivity and specificity of antibody detection deteriorate due to cross-reactions
Solution Approach 1:
The patent extracts and purifies specific Ehrlichia chaffeensis antigens from complex antigen mixtures to create highly specific detection reagents. This extraction of pure antigens eliminates cross-reacting components while maintaining the ability to construct detection assays, thereby resolving the contradiction between ease of manufacture and measurement precision.
Solution Approach 2:
The patent applies local quality by using different purity levels of antigens for different diagnostic purposes. Highly purified antigens are used when high specificity is required (e.g., distinguishing E. chaffeensis from E. canis), while less purified antigens may suffice for preliminary screening, thus balancing manufacturing ease with detection precision based on specific application needs.
2Measurement precision
If highly purified specific reagents are developed, then the sensitivity and specificity of detection assays improve, but the complexity of reagent production increases
Solution Approach 1:
The patent creates recombinant copies of specific Ehrlichia chaffeensis antigens using molecular cloning techniques. These recombinant copies can be produced in large quantities with high purity and consistency, simplifying the overall production process while maintaining high measurement precision in detection assays.
Solution Approach 2:
The patent optimizes various parameters in the antigen purification and recombinant expression processes, including purification conditions, expression system selection, and antigen formulation, to achieve high purity reagents through a streamlined production process that balances complexity with output quality.
3Reliability
If purified polypeptides are used for detection, then cross-reactions with E. canis antibodies are eliminated, but the cost and complexity of obtaining pure antigens increase
Solution Approach 1:
The patent uses recombinant expression systems as intermediaries to produce pure Ehrlichia chaffeensis antigens. These recombinant antigens serve as reliable detection reagents that eliminate cross-reactions while providing a standardized, scalable production method that reduces the overall complexity compared to traditional purification from natural sources.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of these purified polypeptides improves the specificity and sensitivity of antibody detection, distinguishing between Ehrlichia chaffeensis and E. canis infections, enabling accurate diagnosis and reducing false positives from vaccinated animals.
Implementation Method 1
contacting a purified polypeptide comprising SEQ ID NO:1, 2, 3, 5, or 6 with the test sample, under conditions that allow polypeptide/antibody complexes to form
Data Source
AI summary
The invention provides methods and compositions for the detection of Ehrlichia chaffeensis.